美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

基因编辑

483.17

-0.2693-0.06%

涨家数：3

跌家数：2

平家数：- -

市盈率：- -

高：496.58

开：480.56

低：466.88

收：483.21

数据加载中...

Crispr Therapeutics Ag7月21日成交额为4.83亿美元

Editas Medicine, Inc.盘中异动早盘大幅上涨5.07%

美股还能再牛多久？顶流策略师与最新数据深度解读下半年行情

美股研究社

Crispr股票飙升，董事购买价值5150万美元股票

Editas Medicine, Inc.盘中异动早盘急速拉升5.12%

Crispr Therapeutics Ag7月17日成交额为1.22亿美元

Editas Medicine, Inc.盘中异动急速上涨5.14%报2.89美元

Crispr Therapeutics Ag7月11日成交额为1.65亿美元

Editas Medicine, Inc.盘中异动早盘股价大跌5.23%报2.90美元

Beam Therapeutics Inc.盘中异动早盘股价大涨5.06%报20.15美元

Editas Medicine, Inc.盘中异动股价大涨6.30%报2.70美元

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/BK4556/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4556","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4556\",,,,,undefined,":{"symbol":"BK4556","market":"US","secType":"PLATE","nameCN":"基因编辑","latestPrice":482.94037,"timestamp":1753203775668,"preClose":483.20966,"halted":0,"volume":9462819,"delay":0,"changeRate":-0.000557,"floatShares":0,"shares":0,"eps":0,"marketStatus":"交易中","change":-0.269287,"latestTime":"07-22 13:02:55 EDT","open":480.55902,"high":496.57993,"low":466.88425,"amount":221025309.821583,"amplitude":0.061455,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1753214400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":2.526587,"peRate":-5.89096,"turnoverRate":0.01607,"increases":3,"decrements":2,"flats":0,"marketCap":9445032608,"floatMarketCap":9106198496},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4556\",,,,,undefined,":{"symbol":"BK4556","high":496.57993,"amplitude":0.061455,"preClose":483.20966,"low":466.88425,"pbRate":"2.526587","latestPrice":483.16653,"volume":9452182,"delay":0,"open":480.55902,"prevYearClose":376.62552,"prevWeekClose":476.3852,"prevMonthClose":368.039,"prevQuarterClose":368.039,"fiveDayClose":412.1058,"twentyDayClose":350.2954,"sixtyDayClose":336.2601,"secType":"PLATE","market":"US","turnoverRate":0.016063,"peRate":-5.89096,"marketCap":9442959776,"floatMarketCap":9104111840,"timestamp":1753203769873,"nameCN":"基因编辑"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4556\",,,,undefined,":{"bkCode":"BK4556","up":3,"down":2,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4556\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2553288981","title":"Crispr Therapeutics Ag7月21日成交额为4.83亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553288981","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553288981?lang=zh_cn&edition=fundamental","pubTime":"2025-07-22 09:42","pubTimestamp":1753148571,"startTime":"0","endTime":"0","summary":"美东时间2025年7月21日，Crispr Therapeutics Ag成交额为4.83亿美元，成交额较昨日减少25.44%，当日成交量为712.59万股。Crispr Therapeutics Ag于2025年7月21日涨0.31%，报65.33美元，该股过去5个交易日涨15.79%，年初至今涨65.98%，过去60日涨69.51%。Crispr/Cas9是成簇的规则间隔短回文重复序列/Crispr相关蛋白9的缩写，是精确改变基因组DNA特定序列的革命性技术。Crispr第一个获批的药物是Casgevy，它是与Vertex制药公司合作开发的，主要针对镰状细胞病和输血依赖型β-地中海贫血，这两种疾病的医疗需求尚未得到满足。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722094300a45ae81e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722094300a45ae81e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1861558580.USD","LENZ","BK4588","BK4539","CRSP","BK4556","LU1861559042.SGD","BK4139","BK4007","BK4611","BK4585"],"gpt_icon":1},{"id":"2553403394","title":"Editas Medicine, Inc.盘中异动 早盘大幅上涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2553403394","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553403394?lang=zh_cn&edition=fundamental","pubTime":"2025-07-21 21:35","pubTimestamp":1753104916,"startTime":"0","endTime":"0","summary":"北京时间2025年07月21日21时35分，Editas Medicine, Inc.股票出现异动，股价快速拉升5.07%。Editas Medicine, Inc.股票所在的生物技术行业中，整体涨幅为0.07%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250721213517954b2824&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250721213517954b2824&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","BK4139","EDIT"],"gpt_icon":0},{"id":"2553405507","title":"美股还能再牛多久？顶流策略师与最新数据深度解读下半年行情","url":"https://stock-news.laohu8.com/highlight/detail?id=2553405507","media":"美股研究社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553405507?lang=zh_cn&edition=fundamental","pubTime":"2025-07-21 20:33","pubTimestamp":1753101180,"startTime":"0","endTime":"0","summary":"美股投资网将结合前高盛明星策略师Scott Rubner、美国银行首席策略师Michael Hartnett的最新观点，辅以全网最近一手数据，全面拆解未来一个月及下半年美股的多空分歧与交易机会，力求为美股投资者输出可操作的硬核干货。不过，美国银行首席投资策略师Michael Hartnett则发出罕见警告。他指出，美银所有卖出信号均已集体触发，标普500再度逼近新高背景下，短期回调风险大增。尽管市场“火力全开”，顶流策略师对回调风险保持高度警觉。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2025-07-21/doc-infhfvxn7927862.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["ESmain","BK4585","BK4556","LU1861558580.USD","BK4588","MESmain","BK4581","IVV","BK4611","BK4139","SPXU","SPY",".SPX","CRSP","UPRO","SSO","BK4559","SH","OEF","BK4504","LU1861559042.SGD","BK4550","OEX","BK4534","SDS"],"gpt_icon":0},{"id":"2552497340","title":"Crispr股票飙升，董事购买价值5150万美元股票","url":"https://stock-news.laohu8.com/highlight/detail?id=2552497340","media":"英为财情","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552497340?lang=zh_cn&edition=fundamental","pubTime":"2025-07-18 23:10","pubTimestamp":1752851400,"startTime":"0","endTime":"0","summary":"Investing.com -- CRISPR Therapeutics AG 股票周五飙升超过16%，在公司一名董事大量购入股票后创下52周新高。董事Simeon George在提交给美国证券交易委员会的文件中披露，他购买了价值约5150万美元的公司股票。根据监管文件，George于7月16日以每股52.03美元的价格购买了总计989,812股普通股。文件显示，George通过SR One Capital Fund II Aggregator购买了6,510股，通过SR One Capital Opportunities Fund I购买了22,319股，并通过AMZL, LP购买了960,983股。所有这些实体都与SR One Capital Management有关联，George在该公司担任唯一管理成员。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://cn.investing.com/news/stock-market-news/article-93CH-2892729","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"Crispr股票飙升，董事购买价值5150万美元股票","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"investing_news","symbols":["BK4139","CRSP","BK4611","LU1861558580.USD","LU1861559042.SGD","BK4556","BK4588","BK4585"],"gpt_icon":0},{"id":"2552493841","title":"Editas Medicine, Inc.盘中异动 早盘急速拉升5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552493841","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552493841?lang=zh_cn&edition=fundamental","pubTime":"2025-07-18 21:39","pubTimestamp":1752845984,"startTime":"0","endTime":"0","summary":"北京时间2025年07月18日21时39分，Editas Medicine, Inc.股票出现波动，股价大幅上涨5.12%。Editas Medicine, Inc.股票所在的生物技术行业中，整体涨幅为0.09%。其相关个股中，Telomir Pharmaceuticals, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Mesoblast Ltd涨幅较大，Telomir Pharmaceuticals, Inc.、Windtree Therapeutics, Inc.、Tnf Pharmaceuticals, Inc.较为活跃，换手率分别为239.45%、58.70%、19.88%，振幅较大的相关个股有Telomir Pharmaceuticals, Inc.、Clearside Biomedical, Inc.、Athira Pharma, Inc.，振幅分别为35.54%、19.94%、18.37%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071821394595479542&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071821394595479542&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EDIT","BK4556","BK4139"],"gpt_icon":0},{"id":"2552580214","title":"Crispr Therapeutics Ag7月17日成交额为1.22亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552580214","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552580214?lang=zh_cn&edition=fundamental","pubTime":"2025-07-18 09:41","pubTimestamp":1752802907,"startTime":"0","endTime":"0","summary":"美东时间2025年7月17日，Crispr Therapeutics Ag成交额为1.22亿美元，成交额较昨日减少33.00%，当日成交量为220.11万股。Crispr Therapeutics Ag于2025年7月17日跌0.09%，报55.09美元，该股过去5个交易日跌6.63%，年初至今涨39.96%，过去60日涨45.66%。Crispr/Cas9是成簇的规则间隔短回文重复序列/Crispr相关蛋白9的缩写，是精确改变基因组DNA特定序列的革命性技术。Crispr第一个获批的药物是Casgevy，它是与Vertex制药公司合作开发的，主要针对镰状细胞病和输血依赖型β-地中海贫血，这两种疾病的医疗需求尚未得到满足。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718094149a6b0e314&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718094149a6b0e314&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4556","BK4139","LENZ","LU1861559042.SGD","BK4611","BK4585","BK4007","LU1861558580.USD","BK4539","CRSP"],"gpt_icon":0},{"id":"2551121311","title":"Editas Medicine, Inc.盘中异动 急速上涨5.14%报2.89美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551121311","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551121311?lang=zh_cn&edition=fundamental","pubTime":"2025-07-16 21:42","pubTimestamp":1752673336,"startTime":"0","endTime":"0","summary":"北京时间2025年07月16日21时42分，Editas Medicine, Inc.股票出现异动，股价快速上涨5.14%。Editas Medicine, Inc.股票所在的生物技术行业中，整体涨幅为0.75%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507162142179544ed44&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507162142179544ed44&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","BK4139","EDIT"],"gpt_icon":0},{"id":"2550199842","title":"Crispr Therapeutics Ag7月11日成交额为1.65亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550199842","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550199842?lang=zh_cn&edition=fundamental","pubTime":"2025-07-12 09:42","pubTimestamp":1752284541,"startTime":"0","endTime":"0","summary":"美东时间2025年7月11日，Crispr Therapeutics Ag成交额为1.65亿美元，成交额较昨日减少39.51%，当日成交量为289.05万股。Crispr Therapeutics Ag于2025年7月11日跌3.73%，报56.8美元，该股过去5个交易日涨8.87%，年初至今涨44.31%，过去60日涨46.35%。Crispr/Cas9是成簇的规则间隔短回文重复序列/Crispr相关蛋白9的缩写，是精确改变基因组DNA特定序列的革命性技术。Crispr第一个获批的药物是Casgevy，它是与Vertex制药公司合作开发的，主要针对镰状细胞病和输血依赖型β-地中海贫血，这两种疾病的医疗需求尚未得到满足。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250712094225a6a4c706&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250712094225a6a4c706&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRSP","BK4556","BK4007","BK4539","BK4139","BK4585","LENZ","BK4611","LU1861558580.USD","LU1861559042.SGD","BK4588"],"gpt_icon":1},{"id":"2550954097","title":"Editas Medicine, Inc.盘中异动 早盘股价大跌5.23%报2.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550954097","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550954097?lang=zh_cn&edition=fundamental","pubTime":"2025-07-11 22:36","pubTimestamp":1752244561,"startTime":"0","endTime":"0","summary":"北京时间2025年07月11日22时36分，Editas Medicine, Inc.股票出现波动，股价快速下跌5.23%。Editas Medicine, Inc.股票所在的生物技术行业中，整体跌幅为0.86%。其相关个股中，Mink Therapeutics, Inc.、Alterity Therapeutics Limited、Calcimedica, Inc.涨幅较大，Mink Therapeutics, Inc.、Cel-Sci Corporation、Dare Bioscience, Inc.较为活跃，换手率分别为441.21%、195.23%、81.82%，振幅较大的相关个股有Mink Therapeutics, Inc.、Cel-Sci Corporation、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 ，振幅分别为495.47%、74.61%、35.73%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711223602953ee544&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711223602953ee544&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","EDIT","BK4139"],"gpt_icon":0},{"id":"2549528354","title":"Beam Therapeutics Inc.盘中异动 早盘股价大涨5.06%报20.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549528354","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549528354?lang=zh_cn&edition=fundamental","pubTime":"2025-07-08 21:37","pubTimestamp":1751981852,"startTime":"0","endTime":"0","summary":"北京时间2025年07月08日21时37分，Beam Therapeutics Inc.股票出现波动，股价快速上涨5.06%。截至发稿，该股报20.15美元/股，成交量29.487万股，换手率0.29%，振幅4.30%。Beam Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.14%。Beam Therapeutics Inc.公司简介：Beam Therapeutics Inc 是一家生物技术公司，致力于基于其专有的碱基编辑技术开发一类新的精准基因药物，为患有严重疾病的患者提供终身治愈方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708213732953ae602&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708213732953ae602&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4505","BK4139","BK4556","BK4588","BEAM","BK4535","LENZ","BK4611","BK4007","BK4539"],"gpt_icon":0},{"id":"2549752387","title":"Editas Medicine, Inc.盘中异动 股价大涨6.30%报2.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549752387","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549752387?lang=zh_cn&edition=fundamental","pubTime":"2025-07-08 21:36","pubTimestamp":1751981768,"startTime":"0","endTime":"0","summary":"北京时间2025年07月08日21时36分，Editas Medicine, Inc.股票出现波动，股价大幅拉升6.30%。Editas Medicine, Inc.股票所在的生物技术行业中，整体涨幅为0.09%。其相关个股中，Prokidney Corp.、Rallybio Corporation、Humacyte, Inc.涨幅较大，Zyversa Therapeutics, Inc.、Plus Therapeutics, Inc.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为815.16%、130.03%、114.39%，振幅较大的相关个股有Prokidney Corp.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Sonnet Biotherapeutics Holdings, Inc.，振幅分别为37.91%、25.62%、19.03%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708213608979e6359&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708213608979e6359&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","EDIT","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":11,"code":"91000000","status":"200"}]}}